female patients with mental disorders
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with female mental disorders based on DSM-4-TR criteria: continuous administration of antipsychitics normal menstrual cycle before administration of antipsychotics
Exclusion criteria
Exclusion criteria: Patients who are pregnant or may become pregnant Patients with sever hepatic disorder Patients with sever kidney disorder Patients with hypothyroidism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum prolactin level, Visual analogue scale (VAS) assessment at the 2 months after the start of antipsychotics | — |
Secondary
| Measure | Time frame |
|---|---|
| weight change assessment at the 2 months after the start of antipsychotics | — |
Countries
Japan
Contacts
Fujita Health University School of Medicine Department of Psychiatry